Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression

Area of Science:

• Cardiovascular Research
• Biomarker Discovery
• Atherosclerosis Pathogenesis

Background:

• Elevated circulating microparticles (MPs) are linked to cardiovascular diseases, serving as biomarkers of vascular dysfunction.
• Endothelial microparticles (EMPs), submicron vesicles released during endothelial activation or apoptosis, contribute to oxidative stress and vascular inflammation.
• EMPs are implicated in the progression of atherosclerosis, triggered by factors like angiotensin II and lipopolysaccharide.

Purpose of the Study:

• To review the role of endothelial microparticles (EMPs) in the pathogenesis of atherosclerosis.
• To provide updated information on EMPs as potential biomarkers for cardiovascular disease status.

Main Methods:

• Literature review focusing on endothelial microparticles (EMPs) and their involvement in cardiovascular disease.
• Analysis of physiological and pathological pathways of EMP generation and their impact on atherosclerosis.
• Synthesis of evidence regarding EMPs as markers of endothelial dysfunction and disease progression.

Main Results:

• EMPs are key players in cardiovascular disease pathogenesis, influencing oxidative stress, inflammation, and atherosclerosis.
• Multiple pathways, including NADPH oxidase and Rho kinase, contribute to EMP release.
• EMPs can exacerbate disease progression or initiate repair responses, highlighting their complex role.

Conclusions:

• Endothelial microparticles (EMPs) are significant in cardiovascular disease, acting as both contributors to pathogenesis and potential biomarkers.
• Understanding EMPs' dual role in damage and repair is crucial for developing diagnostic and therapeutic strategies.
• Further research into EMPs offers insights into endothelial dysfunction and atherosclerotic plaque development.